As of January 23, 2025, Pulmatrix (PULM) has a market cap of $22.315 million USD. According to our data, Pulmatrix is ranked No.8562 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $22.32 M |
-12.46%
|
Dec 31, 2024 | $25.49 M |
275.27%
|
Dec 29, 2023 | $6.79 M |
-52.06%
|
Dec 30, 2022 | $14.17 M |
-55.71%
|
Dec 31, 2021 | $31.99 M |
-63.19%
|
Dec 31, 2020 | $86.92 M |
38.37%
|
Dec 31, 2019 | $62.82 M |
-64.17%
|
Dec 31, 2018 | $0.18 B |
-82.98%
|
Dec 29, 2017 | $1.03 B |
138.98%
|
Dec 30, 2016 | $0.43 B |
-85.95%
|
Dec 31, 2015 | $3.07 B |
-52.00%
|
Dec 31, 2014 | $6.39 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Innoviva
INVA
|
$1.16 B |
0.000 M
|
USA
|
Amphastar Pharmaceuticals
AMPH
|
$1.74 B |
0.000 M
|
USA
|
MannKind Corp
MNKD
|
$1.70 B |
0.000 M
|
USA
|
Insmed
INSM
|
$14.03 B |
0.000 M
|
USA
|
Theravance Biopharma
TBPH
|
$0.46 B |
-0.000 M
|
|
Verona Pharma
VRNA
|
$4.47 B |
0.000 M
|
UK
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Market Cap | = | PULM Stock Price | * | PULM Shares Outstanding |
= | $6.11 | * | 3.65 M | |
= | $22.32 M |